SCHEMBL6713434

SCHEMBL6713434

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1noc2ccc(S(=O)(=O)N3CCOCC3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALB P02768 1/20 0.46
TP53 P04637 1/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
ATM Q13315 3/20 0.43
CNR1 P21554 1/20 0.42
GPR35 Q9HC97 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
USP2 O75604 1/20 0.42
CREBBP Q92793 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711700 0.91 ALB (0.46) MAPTALBKMT2AMEN1ATM
SCHEMBL6707736 0.89 ALB (0.47) MAPTALBKMT2AMEN1ATM
SCHEMBL6709949 0.87 MAPT (0.47) MAPTMAPK1NPSR1ALBTP53
SCHEMBL6710157 0.83 ALDH1A1 (0.40) MAPTKMT2AMEN1USP2ALDH1A1
SCHEMBL6711857 0.81 ALDH1A1 (0.46) MAPTMAPK1NPSR1TP53KMT2A
SCHEMBL6710218 0.81 HIF1A (0.43) TP53KMT2AMEN1HTT
SCHEMBL6708718 0.80 HIF1A (0.42) MAPTTP53KMT2AMEN1ATM
SCHEMBL6709172 0.80 HIF1A (0.42) MAPTKMT2AMEN1GPR35ALDH1A1
SCHEMBL6707764 0.80 HIF1A (0.41) KMT2AMEN1RXFP1
SCHEMBL6710201 0.79 TDP1 (0.39) MAPTNPSR1TP53KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885MAPK1 2728/4885NPSR1 2999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.